Author's articles
GHP Applauds HIV-Prevention Medicine Trial, Encourages Access to Medicines
By Mark Grayson · 13 years ago
The New England Journal of Medicine recently released the results of a ground-breaking trial of an HIV-prevention method called oral pre-exposure prophylaxis (PrEP). Data from the trial revealed an almost 44 percent reduction of new ...
GHP Amplifies New Report That Stresses Importance of Drug Patents
By Mark Grayson · 14 years ago
"There is a public health crisis in the least developed countries. It is a crisis made by humans and solvable only by humans. There is urgency for governments, businesses, NGOs and academia to collaborate in ...
GHP Fact Sheet Reveals Mexico’s Investment in Biopharmaceutical Sector
By Mark Grayson · 14 years ago
A recent Global Health Progress fact sheet highlights how Mexico’s investment in its biopharmaceutical sector has spurred economic growth, fostered global competitiveness, reduced the health and economic burden of disease on local citizens, and improved ...
Response Papers Call India’s Compulsory Licensing "Counter-Productive"
By Mark Grayson · 14 years ago
Recently, The Department of Industrial Policy and Promotion (DIPP) distributed a discussion paper speculating how India’s compulsory licensing policy impacts the market-availability of low-price life saving drugs. Upon completion of this paper, DIPP requested comments ...
GHP Fact Sheet Projects China to Become Major Biopharmaceutical Player
By Mark Grayson · 14 years ago
Data revealed in Global Health Progress’ (GHP) new fact sheet shows that China is projected to become one of the world’s major biopharmaceutical players, along with the U.S., Europe, and Japan, in the next fifteen ...
GHP Fact Sheet Highlights Russia’s Commitment to Biotechnology Sector
By Mark Grayson · 14 years ago
Global Health Progress (GHP) released a new fact sheet highlighting Russia’s commitment to expanding and promoting its biotechnology sector. Although the biopharmaceutical sector in Russia is less developed than other markets, the sector is making ...
Global Health Progress Highlights Growth of Brazil’s Biotechnology Sector
By Mark Grayson · 14 years ago
Global Health Progress (GHP) released a new report that reveals how the biopharmaceutical sector in Brazil, the tenth largest biopharmaceutical market in the world and the largest in Latin America, is an important driver for ...
Global Health Progress highlights growth of Turkey’s biotechnology sector
By Mark Grayson · 14 years ago
A recent report on the biopharmaceutical sector presence, employment, economic output and research and development activity in the European States highlights Turkey’s long-term prospects for growth. The report notes that the industry is creating a ...
Global Health Progress agrees criticizing "Big Pharma" is not the answer
By Mark Grayson · 14 years ago
In recent commentary in the Wall Street Journal, Alec van Gelder, Project Director at the International Policy Network wrote that strong intellectual property rights are critical to strengthening Africa’s health care system. He criticized statements ...
Global Health Progress Epitomizes Clinton, Gates’ Call for "Efficiency Savings"
By Mark Grayson · 14 years ago
During a recent international conference in Vienna for 20,000 AIDS scientists, health workers and activists, former U.S. President Bill Clinton and Microsoft founder Bill Gates urged AIDS activists to try to generate the most value ...
IPN Discusses Unitaid Pool for Pharmaceutical Patents
By Mark Grayson · 14 years ago
International Policy Network (IPN), a nongovernmental educational organization focused on highlighting the role of free society institutions in social and economic development, recently discussed some of the limitations of the Unitaid pool for pharmaceutical patents. ...
Advance Market Commitment Encourages Access to Medicine in Poor Countries
By Mark Grayson · 14 years ago
The governments of Italy, the United Kingdom, Canada, Russia, and Norway and the Bill & Melinda Gates Foundation announce the first long-term agreements made by pharmaceutical firms to provide increased access to medicine by supplying ...